{"id":1906,"date":"2019-09-26T18:29:17","date_gmt":"2019-09-26T16:29:17","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=1906"},"modified":"2024-06-19T14:21:04","modified_gmt":"2024-06-19T12:21:04","slug":"enfermedades-de-cabeza-y-cuello","status":"publish","type":"page","link":"https:\/\/idibell.cat\/es\/investigacion\/area-de-cancer\/programa-de-mecanismos-moleculares-y-terapia-experimental-en-oncologia-oncobell\/enfermedades-de-cabeza-y-cuello\/","title":{"rendered":"Enfermedades de Cabeza y Cuello"},"content":{"rendered":"\n<h1>\n\t\tEnfermedades de cabeza y cuello\n\t<\/h1>\n<h3>\n\t\tResumen\n\t<\/h3>\n\t<p>El grupo de investigaci\u00f3n de cabeza y cuello, en su l\u00ednea de investigaci\u00f3n oncol\u00f3gica, estudia nuevas dianas terap\u00e9uticas y biomarcadores predictivos de respuesta a QMT, RT e inmunoterapia, el papel del virus del papiloma humano (HPV) y el manejo diferencial de los tumores HPV+, el tratamiento trans-oral del C\u00e1ncer de Laringe con l\u00e1ser CO2 y Cirug\u00eda Rob\u00f3tica, cirug\u00eda reconstructiva y rehabilitaci\u00f3n fonatoria de los pacientes laringectomizados.<\/p>\n<h2>406<\/h2>\n<h2>Publicaciones<\/h2>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2020\/04\/511-malaltiescapcoll-mmanos-def.jpg\" alt=\"511-malaltiescapcoll-mmanos-def\" itemprop=\"image\" height=\"300\" width=\"600\" title=\"511-malaltiescapcoll-mmanos-def\" onerror=\"this.style.display='none'\"  \/>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-0\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-0\">L\u00edneas estrat\u00e9gicas<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-0\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-0\"><i>Expand<\/i><\/a>\n\t\t\t\t\t<ul>\n<li>Papilomatosis respiratoria recurrente. aspectos etiol\u00f3gicos, cl\u00ednicos y de tratamiento, efectos de las vacunas en la evoluci\u00f3n y control de esta enfermedad.<\/li>\n<li>La nueva era de la cirug\u00eda de orejas: cirug\u00eda endosc\u00f3pica de orejas, t\u00e9cnicas seguras y resultados.<\/li>\n<li>Impactos de la composici\u00f3n corporal en el c\u00e1ncer de cabeza y cuello<\/li>\n<li>Nuevas t\u00e9cnicas para el manejo quir\u00fargico de la telangiectasia hemorr\u00e1gica hereditaria (enfermedad de Rendu-Osler-Weber)<\/li>\n<li>Los efectos de los tratamientos biol\u00f3gicos en la rinosinusitis cr\u00f3nica con poliposis.<\/li>\n<li>Radi\u00f3mica y tumores de cabeza y cuello<\/li>\n<li>La implementaci\u00f3n de la inteligencia artificial en el diagn\u00f3stico y manejo de los tumores de cabeza y cuello<\/li>\n<li>Evaluaci\u00f3n por EC de la anatom\u00eda de los senos paranasales para mejorar los resultados y la seguridad de la cirug\u00eda endosc\u00f3pica funcional de los senos paranasales<\/li>\n<li>Implementaci\u00f3n y resultados de la cirug\u00eda rob\u00f3tica en c\u00e1ncer de cabeza y cuello<\/li>\n<li>VPH y c\u00e1ncer de cabeza y cuello<\/li>\n<\/ul>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-1\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-1\">Publicaciones seleccionadas<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-1\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-1\"><i>Expand<\/i><\/a>\n\t\t\t\t\t<ul>\n<li>Spreaflco,A;Heirali,AA;Araujo,DV;Tan,TJ;Oliva,M;Schneeberger,PHH;Chen,B et al, <strong>First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial)<\/strong>, Ann. Oncol., 2023;34(6):520-530, doi:10.1016\/j.annonc.2023.02.011<\/li>\n<li>Mosteiro,M;Azuara,D;Villatoro,S;Alay,A;Gausachs,M;Varela,M;Baixeras,N et al, <strong>Molecular profiling and feasibility using a comprehensive hybrid capture panel on a consecutive series of non-small-cell lung cancer patients from a single centre<\/strong>, ESMO Open, 2023;8(6):doi:10.1016\/j.esmoop.2023.102197<\/li>\n<li>Hijazo Pechero,S;Alay,A;Cordero,D;Marin,R;Vilari\u00f1o,N;Palmero,R;Brenes,J et al, <strong>Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implications<\/strong>, Mol. Oncol., 2023;18(2):453-470, doi:10.1002\/1878-0261.13550<\/li>\n<li>Naval Baudin,P;Pons Escoda,A;Camins,\u00c0;Arroyo,P;Viveros,M;Castell,J;Cos,M et al, <strong>Deeply 3D-T1-TFE hypointense voxels are characteristic of phase-rim lesions in multiple sclerosis<\/strong>., Eur. Radiol., 2023;34(2):1337-1345, doi:10.1007\/s00330-023-09784-w<\/li>\n<li>Maj\u00f3s,C;Pons Escoda,A;Naval,P;Guell,A;Lucas,A;Vidal,N;Cos,M et al, <strong>Proton MR spectroscopy shows improved performance to segregate high-grade astrocytoma subgroups when defined with the new 2021 World Health Organization classification of central nervous system tumors<\/strong>, Eur. Radiol., 2023;doi:10.1007\/s00330-023-10138-9<\/li>\n<\/ul>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-2\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-2\">Proyectos seleccionados<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-2\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-2\"><i>Expand<\/i><\/a>\n\t\t\t\t\t<ul>\n<li>19ACL261. <strong>ESTUDIO CL\u00cdNICO DE FASE 3, ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO DE PEMBROLIZUMAB (MK-3475) CON O SIN LENVATINIB (E7080\/MK-7902) PARA EVALUAR LA SEGURIDAD Y LA EFICACIA DE PEMBROLIZUMAB Y LENVATINIB COMO INTERVENCI\u00d3N DE PRIMERA L\u00cdNEA EN UNA P<\/strong>. MERCK SHARP &amp; DOHME ESPA\u00d1A S.A.. Budget: 313.548\u20ac. 2019- . PI: OLIVA BERNAL, MARC.<\/li>\n<li>20ACL093. <strong>A RANDOMIZED, DOUBLE-BLIND, ADAPTIVE, PHASE II\/III STUDY OF GSK3359609 OR PLACEBO IN COMBINATION WITH PEMBROLIZUMAB FOR FIRST-LINE TREATMENT OF PD-L1 POSITIVE RECURRENT\/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA<\/strong>. GlaxoSmithKline Research &amp; Development Limited;GlaxoSmithKline, S.A. Budget: 236.335,84\u20ac. 2020- . PI: Plana Serrahima, Mar\u00eda.<\/li>\n<li>2023-491-1. <strong>PHASE 1-2 STUDY INVESTIGATING SAFETY, TOLERABILITY, PHARMACOKINETICS AND PRELIMINARY ANTITUMOR ACTIVITY OF ANTI-TIM-3 MONOCLONAL ANTIBODY BGB-A425 IN COMBINATION WITH ANTI-PD-1 MONOCLONAL ANTIBODY TISLELIZUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS<\/strong>. BEIGENE SWITZERLAND GMBH. Budget: 233.370\u20ac. 2023- . PI: OLIVA BERNAL, MARC.<\/li>\n<li>20ACL112. <strong>Estudio cl\u00ednico de fase 2, aleatorizado, abierto y de tres grupos para evaluar la seguridad y la eficacia de lenvatinib (E7080\/MK-7902) en combinaci\u00f3n con pembrolizumab (MK-3475) frente a la quimioterapia de referencia y lenvatinib en monoterapia en parti<\/strong>. MERCK SHARP &amp; DOHME ESPA\u00d1A S.A.. Budget: 215.055\u20ac. 2020- . PI: Taberna Sanz, Miren.<\/li>\n<li>2023-351-1. <strong>ENSAYO DE FASE I, ABIERTO, DE ESCALADO DE DOSIS DE BI 1831169 EN MONOTERAPIA Y EN COMBINACI\u00d3N CON EZABENLIMAB EN PACIENTES CON TUMORES S\u00d3LIDOS AVANZADOS O METAST\u00c1SICOS<\/strong>. Boehringer Ingelheim Espa\u00f1a, S.A.. Budget: 201.126\u20ac. 2023- . PI: OLIVA BERNAL, MARC.<\/li>\n<\/ul>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-3\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-3\">M\u00e1s informaci\u00f3n<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-3\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-3\"><i>Expand<\/i><\/a>\n\t\t\t\t\t<p><strong>Otras l\u00edneas de investigaci\u00f3n:<\/strong> El papel del VPH en los trastornos nasales benignos; Evaluaci\u00f3n TC de la anatom\u00eda nasosinusal y sus implicaciones quir\u00fargicas; Trastorno gen\u00e9tico y tratamiento quir\u00fargico para pacientes con enfermedad de Rendu Osler Weber; Impacto de la composici\u00f3n corporal en el c\u00e1ncer de cabeza y cuello en tratamientos espec\u00edficos.<\/p>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2020\/04\/Manel-Ma\u00f1os-150x150.jpg\" alt=\"Manel Ma\u00f1os\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Manel Ma\u00f1os\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tMa\u00f1os Pujol, Manel\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:mmanos@idibell.cat\" title=\"mmanos@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\tmmanos@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n<h2>\n\t\tInvestigadores principales\n\t<\/h2>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2020\/04\/Manel-Ma\u00f1os-150x150.jpg\" alt=\"Manel Ma\u00f1os\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Manel Ma\u00f1os\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tMa\u00f1os Pujol, Manel\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:mmanos@idibell.cat\" title=\"mmanos@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\tmmanos@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2021\/06\/Marc-Oliva-Bernal-150x150.jpg\" alt=\"Marc-Oliva-Bernal\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Marc-Oliva-Bernal\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tOliva Bernal, Marc\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:moliva@idibell.cat\" title=\"moliva@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\tmoliva@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2021\/06\/Lorena-Arribas-Hortiguela.jpg\" alt=\"Lorena-Arribas-Hortig\u00fcela\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Lorena-Arribas-Hortig\u00fcela\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tArribas Hortig\u00fcela, Lorena\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:larribas@idibell.cat\" title=\"larribas@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\tlarribas@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\tENLACES RELACIONADOS\n\t<\/h4>\n<h4>\n\t\t<a href=\"https:\/\/twitter.com\/OlivaM_Onc\" title=\"@OlivaM_Onc\" target=\"_blank\" rel=\"noopener\">\n\t\t@OlivaM_Onc\n\t\t<\/a>\n\t<\/h4>\n<h2>\n\t\tEquipo\n\t<\/h2>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-0\" data-index=\"0\" aria-selected=\"true\" aria-controls=\"fl-tabs--panel-0\" aria-expanded=\"true\" role=\"tab\" tabindex=\"0\">\t\t\t\tJefes\/as de grupo\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-1\" data-index=\"1\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-1\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tInvestigadores\/as principales\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-2\" data-index=\"2\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-2\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tInvestigadores\/as cl\u00ednicos\/as\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-3\" data-index=\"3\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-3\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tSoporte cient\u00edfico\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-4\" data-index=\"4\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-4\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tColaboradores\/as\t\t\t\t<\/a>\n\t\t\t\t\t\tJefes\/as de grupo\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Ma\u00f1os Pujol, Manel<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadores\/as principales\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Oliva Bernal, Marc<\/li>\n<li>Arribas Hortig\u00fcela, Lorena<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadores\/as cl\u00ednicos\/as\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Handam Zavarce, Miriam<\/li>\n<li>Nogues Orp\u00ed, Julio<\/li>\n<li>Cisa Lluis, Enric<\/li>\n<li>Melero Luque, Mireia<\/li>\n<li>Bermejo Sergu, Oriol<\/li>\n<li>Tornero Salto, Jordi<\/li>\n<li>Goma Gallego, Montserrat<\/li>\n<li>Cruellas Taischik, Francesc<\/li>\n<li>Gonzalez Compta, Xavier<\/li>\n<li>Mari Roig, Antoni<\/li>\n<li>Lozano Borbalas, Alicia<\/li>\n<li>Plana Serrahima, Maria<\/li>\n<li>Cos Domingo, Monica<\/li>\n<li>Rodriguez Bel, Laura<\/li>\n<li>Arranz Obispo, Carlos<\/li>\n<li>Brenes Castro, Jesus<\/li>\n<li>Penella Prat, Anna<\/li>\n<li>Brunet Garcia, Aina<\/li>\n<li>Bartel Arensburg, Ricardo<\/li>\n<li>Mesalles Ruiz, Marta<\/li>\n<li>Portillo Medina, Alex<\/li>\n<li>Morla, Arnaud Gerard<\/li>\n<li>Cusc\u00f3 Albors, Silvia<\/li>\n<li>Fulla Camp\u00ed, Marta<\/li>\n<li>Lares Archer, Henri R<\/li>\n<\/ul>\n\t\t\t\t\t\tSoporte cient\u00edfico\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Sospedra Martinez, Maria<\/li>\n<\/ul>\n\t\t\t\t\t\tColaboradores\/as\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Rovira Casas, Aleix<\/li>\n<\/ul>\n<h2>\n\t\tNoticias relacionadas\n\t<\/h2>\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/10029\" content=\"IDIBELL celebra el Kickoff Meeting AES 2019 sobre Proyectos de Investigaci\u00f3n en Salud financiados por el ISCIII\" \/><meta itemprop=\"datePublished\" content=\"2020-03-03\" \/><meta itemprop=\"dateModified\" content=\"2022-12-20\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/es\/author\/erigin\/\" \/><meta itemprop=\"name\" content=\"Idibell\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/es\/2020\/03\/idibell-celebra-el-kickoff-meeting-aes-2019-sobre-proyectos-de-investigacion-en-salud-financiados-por-el-isciii\/\" title=\"IDIBELL celebra el Kickoff Meeting AES 2019 sobre Proyectos de Investigaci\u00f3n en Salud financiados por el ISCIII\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/es\/2020\/03\/idibell-celebra-el-kickoff-meeting-aes-2019-sobre-proyectos-de-investigacion-en-salud-financiados-por-el-isciii\/\" title=\"IDIBELL celebra el Kickoff Meeting AES 2019 sobre Proyectos de Investigaci\u00f3n en Salud financiados por el ISCIII\">IDIBELL celebra el Kickoff Meeting AES 2019 sobre Proyectos de Investigaci\u00f3n en Salud financiados por el ISCIII<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/es\/author\/erigin\/\">Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t03\/03\/2020\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/10107\" content=\"La investigadora Purificaci\u00f3n Mu\u00f1oz recibe el V premio Mart\u00ed Via\" \/><meta itemprop=\"datePublished\" content=\"2019-11-29\" \/><meta itemprop=\"dateModified\" content=\"2021-07-28\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/es\/author\/erigin\/\" \/><meta itemprop=\"name\" content=\"Idibell\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2020\/05\/pmunoz_premi_marti_via-scaled.jpg\" \/><meta itemprop=\"width\" content=\"2560\" \/><meta itemprop=\"height\" content=\"1920\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/es\/2019\/11\/la-investigadora-purificacion-munoz-recibe-el-v-premio-marti-via\/\" title=\"La investigadora Purificaci\u00f3n Mu\u00f1oz recibe el V premio Mart\u00ed Via\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/es\/2019\/11\/la-investigadora-purificacion-munoz-recibe-el-v-premio-marti-via\/\" title=\"La investigadora Purificaci\u00f3n Mu\u00f1oz recibe el V premio Mart\u00ed Via\">La investigadora Purificaci\u00f3n Mu\u00f1oz recibe el V premio Mart\u00ed Via<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/es\/author\/erigin\/\">Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t29\/11\/2019\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/10357\" content=\"El c\u00e1ncer de t\u00fa a t\u00fa: pacientes, m\u00e9dicos, investigadors y activistas de la lucha contra el c\u00e1ncer dialogan y se abren a la ciudadan\u00eda\" \/><meta itemprop=\"datePublished\" content=\"2018-09-13\" \/><meta itemprop=\"dateModified\" content=\"2021-07-28\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/es\/author\/erigin\/\" \/><meta itemprop=\"name\" content=\"Idibell\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2020\/05\/elcancerdetuatu2.jpg\" \/><meta itemprop=\"width\" content=\"700\" \/><meta itemprop=\"height\" content=\"409\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/es\/2018\/09\/el-cancer-de-tu-a-tu-pacientes-medicos-investigadors-y-activistas-de-la-lucha-contra-el-cancer-dialogan-y-se-abren-a-la-ciudadania\/\" title=\"El c\u00e1ncer de t\u00fa a t\u00fa: pacientes, m\u00e9dicos, investigadors y activistas de la lucha contra el c\u00e1ncer dialogan y se abren a la ciudadan\u00eda\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/es\/2018\/09\/el-cancer-de-tu-a-tu-pacientes-medicos-investigadors-y-activistas-de-la-lucha-contra-el-cancer-dialogan-y-se-abren-a-la-ciudadania\/\" title=\"El c\u00e1ncer de t\u00fa a t\u00fa: pacientes, m\u00e9dicos, investigadors y activistas de la lucha contra el c\u00e1ncer dialogan y se abren a la ciudadan\u00eda\">El c\u00e1ncer de t\u00fa a t\u00fa: pacientes, m\u00e9dicos, investigadors y activistas de la lucha contra el c\u00e1ncer dialogan y se abren a la ciudadan\u00eda<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/es\/author\/erigin\/\">Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t13\/09\/2018\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/11347\" content=\"La p\u00e9rdida de una prote\u00edna hace 'saltar' el tumor al ganglio linf\u00e1tico\" \/><meta itemprop=\"datePublished\" content=\"2012-03-06\" \/><meta itemprop=\"dateModified\" content=\"2023-03-02\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/es\/author\/erigin\/\" \/><meta itemprop=\"name\" content=\"Idibell\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2012\/03\/Clipboard-2-1.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/es\/2012\/03\/la-perdida-de-una-proteina-hace-saltar-el-tumor-al-ganglio-linfatico\/\" title=\"La p\u00e9rdida de una prote\u00edna hace 'saltar' el tumor al ganglio linf\u00e1tico\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/es\/2012\/03\/la-perdida-de-una-proteina-hace-saltar-el-tumor-al-ganglio-linfatico\/\" title=\"La p\u00e9rdida de una prote\u00edna hace 'saltar' el tumor al ganglio linf\u00e1tico\">La p\u00e9rdida de una prote\u00edna hace &#8216;saltar&#8217; el tumor al ganglio linf\u00e1tico<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/es\/author\/erigin\/\">Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t06\/03\/2012\t\t\t\t\t\t\t\n\t\t<!-- .pp-content-posts -->\n\n","protected":false},"excerpt":{"rendered":"<p>Enfermedades de cabeza y cuello Resumen El grupo de investigaci\u00f3n de cabeza y cuello, en su l\u00ednea de investigaci\u00f3n oncol\u00f3gica, estudia nuevas dianas terap\u00e9uticas y biomarcadores predictivos de respuesta a QMT, RT e inmunoterapia, el papel del virus del papiloma humano (HPV) y el manejo diferencial de los tumores HPV+, el tratamiento trans-oral del C\u00e1ncer [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":448,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-1906","page","type-page","status-publish","hentry"],"publishpress_future_action":{"enabled":false,"date":"2024-11-12 01:38:21","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/1906"}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=1906"}],"version-history":[{"count":11,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/1906\/revisions"}],"predecessor-version":[{"id":24593,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/1906\/revisions\/24593"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/448"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=1906"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}